Amrutanjan Heal shares closed at 612.15 on February 13, 2025 (NSE) and has given -16.59% returns over last 6 months and -4.92% over the last 12 months. Reported Standalone quarterly numbers are: Net Sales at Rs 122.75 crore in December 2024 up 4.92%. EBITDA stands at Rs. 27.71 crore in January 2024 up 9.35% from Rs. 25.34 crore in Dec 2023. EPS has increased to Rs. 6.66 in December 2025 from Rs 6.05 in December 2023, according to the company’s results. The company’s shareholding is as follows: Pledged/Encumbered – Number of shares (Crores) — — — – Per. of Shares (as a % of the total sh. of Promoters and Promoter Group Shareholding) Non-encumbered — –. — – per. share of shares of the company (as % of total Share Cap. of theCompany) — — — — Source : Dion Global Solutions Limited.
